Suchbegriff wählen

Pill

„Machen Sie’s So!“ – Amazon Prime Video und CBS schließen exklusiven Deal zur neuen Star Trek-Serie über Jean-Luc…

München (ots) - Die Episoden starten jeweils nur 24 Stunden nach der US-Premiere bei CBS All Access exklusiv bei Prime Video in über 200 Ländern und Gebieten - Die noch unbetitelte Star Trek-Serie folgt dem ikonischen Charakter Jean-Luc Picard im nächsten Kapitel seines Lebens Amazon Prime Video und CBS schalten auf Warp-Geschwindigkeit: Die neue, noch unbetitelte Star Trek-Serie über Jean-Luc Picard findet in über 200 Ländern und Gebieten bei Prime Video ein neues Zuhause. Im Rahmen des mehrjährigen Deals

Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-Cholesterol Lowering and Reduced hsCRP in…

Munich and Ann Arbor, Michigan (ots/PRNewswire) - Daiichi Sankyo Europe GMbH (hereafter, 'Daiichi Sankyo') and Esperion Therapeutics (NASDAQ: ESPR) announced today that results from the 345 patient, 24-week, Phase 3 double-blind, placebo-controlled study of bempedoic acid (CLEAR Serenity, also known as Study 3) were published in the Journal of the American Heart Association (JAHA). Bempedoic acid is being developed as a complementary, convenient, once-daily, oral therapy for the treatment of patients with elevated

CLEAR Wisdom Demonstrated First-in-class, Oral, Once-daily, ACL Inhibitor Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced…

Munich and Ann Arbor, Michigan (ots/PRNewswire) - Daiichi Sankyo Europe GMbH (hereafter, 'Daiichi Sankyo') and Esperion (NASDAQ: ESPR) today announced that the Phase 3 results from CLEAR Wisdom of first-in-class, oral, once-daily ATP citrate lyase (ACL) inhibitor, bempedoic acid, were presented at the ACC Scientific Sessions & Expo in New Orleans. Bempedoic acid is being developed as a complementary, convenient, once-daily, oral therapy for the treatment of patients with elevated low-density lipoprotein cholesterol

Daiichi Sankyo Europe and Esperion Announce Validation of theMarketing Authorisation Application (MAA) for Bempedoic Acid and theBempedoic…

Ezetimibe Fixed Dose Combination Tablet Munich and Ann Arbor, Michigan (ots/PRNewswire) - * Application is based on results of a robust development programme, which demonstrated that bempedoic acid was well tolerated and efficacious for chronic use * Bempedoic acid is a first-in-class, oral, once-daily ATP Citrate Lyase (ACL) inhibitor that reduces cholesterol and fatty acid synthesis in the liver * Bempedoic acid expands Daiichi Sankyo Europe's commitment to cardiovascular care and the development of

Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid

Ezetimibe Combination Tablet Munich (ots/PRNewswire) - * Daiichi Sankyo Europe will market oral bempedoic acid and bempedoic acid / ezetimibe combination tablet in the European Economic Area and Switzerland * Bempedoic acid is a first-in-class, oral, once-daily ATP Citrate Lyase (ACL) inhibitor that reduces cholesterol and fatty acid synthesis in the liver * Bempedoic acid and its fixed dose combination tablet with ezetimibe will offer additional treatment options for the large number of patients unable to

Landstraße: Paläste-Dokumentation und Bilder-Schau

Wien (OTS/RK) - Zwei neue Sonder-Ausstellungen werden demnächst im Bezirksmuseum Landstraße (3., Sechskrügelgasse 11) gezeigt: Am Freitag, 16. November, fängt um 19.00 Uhr die frei zugängliche Eröffnungsveranstaltung an. Zu sehen gibt es die Dokumentation „Verschwundene Paläste der Landstraße“ sowie die Gemälde-Schau „Frauen und Landschaften“ (Bilder von Ilse Ditz). Diese beiden Ausstellungen laufen bis Mittwoch, 13. Februar 2019. Jeweils am Sonntag (10.00 bis 12.00 Uhr) und am Mittwoch (16.00 bis 18.00 Uhr) können die